Assure (NASDAQ: IONM ) stock is soaring higher on Thursday after the neuromonitoring surgical support services company withdrew a share offering. Assure notes that it no longer plans to move forward with a proposed stock offering that was announced on May 3.
Assure (NASDAQ: IONM ) stock is taking a beating on Thursday after the intraoperative neuromonitoring surgical support services company terminated a merger agreement with Danam Health. Assure was planning to merge a subsidiary with Danam Health.
| Diversified Telecommunication Services Industry | Communication Services Sector | John Allen Farlinger CEO | OTC PINK Exchange | 04625J402 CUSIP |
| US Country | 95 Employees | - Last Dividend | 9 Jul 2024 Last Split | 19 Jul 2017 IPO Date |
Assure Holdings Corp. is a distinguished provider that specializes in delivering technical and professional intraoperative neuromonitoring surgical support services across the United States. Based in Englewood, Colorado, the company leverages its expertise to enhance surgical outcomes through comprehensive monitoring solutions. Assure Holdings Corp. focuses on supporting surgeries in various medical fields including neurosurgery, spine surgery, cardiovascular procedures, orthopedic operations, and surgeries related to the ear, nose, and throat among others. By offering a blend of clinical and operational services, the company plays a critical role in ensuring the safety and success of invasive procedures by working closely with surgeons and medical facilities.
Assure Holdings Corp. provides specialized technical support during surgeries through intraoperative neuromonitoring. This service is crucial for a variety of surgical procedures including neurosurgery, spine surgery, and cardiovascular operations, offering real-time monitoring of patients' nervous systems to reduce the risk of postoperative neurological deficits.
The company offers professional support services that encompass the scheduling of interoperative neurophysiologists and supervising practitioners. This ensures that every surgical procedure is attended by professionals who specialize in neuromonitoring, thereby enhancing patient safety and procedural efficiency.
With an emphasis on real-time data, Assure Holdings provides continuous monitoring during surgeries. This capability allows for immediate response to any neural pathway changes, facilitating interventions that can prevent potential harm to the patient.
Patient advocacy is a cornerstone of Assure Holdings’ services, ensuring that the interests and safety of the patient are prioritized throughout the surgical process. This includes thorough consultation and communication with the patient and their family regarding the neuromonitoring process.
To complement their clinical services, Assure Holdings Corp. also provides billing services. This operational support is designed to streamline the financial aspects of the neuromonitoring services, making the process as seamless and efficient as possible for both the medical facilities and the patients.